Point72 Asia (Singapore)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80.4K | Buy |
3,726
+805
| +28% | +$17.4K | 0.01% | 511 |
|
2025
Q1 | $48.5K | Sell |
2,921
-14,053
| -83% | -$233K | 0.01% | 576 |
|
2024
Q4 | $311K | Buy |
+16,974
| New | +$311K | 0.08% | 183 |
|
2024
Q3 | – | Sell |
-4,538
| Closed | -$73.7K | – | 923 |
|
2024
Q2 | $73.7K | Sell |
4,538
-11,980
| -73% | -$195K | 0.02% | 555 |
|
2024
Q1 | $305K | Buy |
+16,518
| New | +$305K | 0.08% | 276 |
|